rs2307109
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2
The NM_001999.4(FBN2):c.6833C>T(p.Thr2278Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,613,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001999.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN2 | NM_001999.4 | c.6833C>T | p.Thr2278Met | missense_variant | 54/65 | ENST00000262464.9 | NP_001990.2 | |
FBN2 | XM_017009228.3 | c.6680C>T | p.Thr2227Met | missense_variant | 53/64 | XP_016864717.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN2 | ENST00000262464.9 | c.6833C>T | p.Thr2278Met | missense_variant | 54/65 | 1 | NM_001999.4 | ENSP00000262464 | P1 | |
FBN2 | ENST00000703783.1 | n.3617C>T | non_coding_transcript_exon_variant | 29/38 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251276Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135782
GnomAD4 exome AF: 0.000138 AC: 202AN: 1461702Hom.: 0 Cov.: 33 AF XY: 0.000132 AC XY: 96AN XY: 727168
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152270Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74452
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2014 | Lines of evidence used in support of classification: UNCERTAIN: Alteration(s) of Uncertain Clinical Significance Detected - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 28, 2017 | A variant of uncertain significance has been identified in the FBN2 gene. The T2278M variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is observed in 10/8644 (0.1%) alleles from individuals of East Asian ancestry in the Exome Aggregation Consortium (ExAC) datset (Lek et al., 2016; Exome Variant Server). This substitution occurs at a position that is conserved in mammals and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Furthermore, while the T2278M variant is located within a calcium-binding EGF-like domain of the FBN2 gene, it does not affect a Cysteine residue in this domain. Cysteine substitutions in the calcium-binding EGF-like domains represent the majority of pathogenic missense changes associated with congenital arachnodactyly (Collod-Beroud et al., 2003; Frédéric et al., 2009). Nevertheless, the T2278M variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. - |
Congenital contractural arachnodactyly Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 15, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at